Clinical Trial Update: A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse [Phase 2]

View source ↗

Summary

Phase 2 study to evaluate Brenipatide for relapse prevention in adults who have quit smoking.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Brenipatide

Snippet

Sponsor: Eli Lilly and Company | Conditions: Smoking | Phase 2 | Status: RECRUITING